By John Harbison|2017-02-20T06:55:17-08:00November 23, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Cognition Therapeutics Sees Lilly Solanezumab Clinical Trial Results as Support for its Unique Mechanism for Treatment of Alzheimer’s Disease
